Related by context. All words. (Click for frequent words.) 70 cognitive dysfunction 68 cognitive impairment 67 neurocognitive deficits 66 cognitive impairments 66 behavioral abnormalities 65 alexithymia 65 cognitive function 65 cognitive functioning 64 neuronal dysfunction 64 cognitive 64 brain lesions 64 metabolic abnormalities 64 neuropsychiatric symptoms 64 neurological abnormalities 63 nerve degeneration 63 parkinsonism 63 cognition 63 neuropsychological deficits 63 neurological impairment 63 hippocampal volume 63 neurologic disorders 62 mild cognitive 62 hippocampal function 62 synaptic function 62 neuropsychological impairments 62 sleep disturbances 62 neurodegeneration 62 neuropsychological functioning 62 cognitive abilities 62 neurodevelopmental 62 neurodevelopment 62 somatic symptoms 61 cognitive decline 61 neurocognitive 61 psychiatric disorders 61 depressive symptoms 61 mitochondrial dysfunction 61 cognitive functions 61 neuroimaging studies 61 neurological impairments 61 HPA axis 61 motor neuron degeneration 61 psychotic symptoms 61 ADHD symptoms 61 cognitive domains 61 thyroid dysfunction 60 extrapyramidal symptoms 60 underlying pathophysiology 60 neuromotor 60 impaired cognition 60 neuropathological 60 neurodevelopmental disorder 60 cerebellar 60 dyskinesias 60 pharmacological interventions 60 neurologic symptoms 60 behavioral disturbances 60 neurodevelopmental outcomes 60 synaptic plasticity 60 generalized seizures 60 amyloid deposition 59 psychosocial functioning 59 premorbid 59 biochemical abnormalities 59 neuroanatomical 59 Parkinsonian 59 dopaminergic therapy 59 abnormalities 59 neurocognitive impairment 59 developmental abnormalities 59 utero exposure 59 compensatory mechanisms 59 neurological 59 axonal damage 59 Parkinson disease PD 59 neurological dysfunction 59 tau pathology 59 hyperexcitability 58 neurological degeneration 58 neuropsychiatric disorders 58 Cognitive impairment 58 poststroke 58 euthymic patients 58 parkinsonian 58 daytime drowsiness 58 mood disorders 58 neurobehavioral 58 mGluR2 NAM 58 psychomotor 58 neurodevelopmental disorders 58 subclinical atherosclerosis 58 phonic tics 58 comorbid disorders 58 neuronal plasticity 58 subclinical hypothyroidism 58 prefrontal cortical 58 neurobiological 58 cardiac abnormalities 58 neurodevelopmental outcome 58 T1DM 58 tic disorders 58 recurrent abdominal pain 58 apraxia 58 dysregulation 58 subcortical 58 hemiparesis 58 disorders 58 parkinsonian symptoms 58 neurologic 58 neuropsychological 58 dysregulated 58 maladaptive behaviors 58 psychostimulants 58 microglial activation 58 behavioral disinhibition 57 cortical excitability 57 neurocognitive function 57 carotid atherosclerosis 57 GBA mutations 57 hippocampal atrophy 57 molecular mechanisms underlying 57 SRBD 57 overactive bladder symptoms 57 auditory processing 57 subclinical 57 impulsive behaviors 57 Korsakoff syndrome 57 proliferative diabetic retinopathy 57 cardiac fibrosis 57 cerebral ischemia 57 glutamate receptors 57 biochemical imbalance 57 sequelae 57 optic neuritis 57 parietal cortices 57 NMDA receptors 57 neuropsychiatric diseases 57 dietary interventions 57 microdeletion 57 motor tics 57 idiopathic Parkinson disease 57 temporoparietal 57 Wernicke Korsakoff syndrome 57 Angelman syndrome 57 term potentiation LTP 57 sensorimotor 57 hyperactivity inattention 57 renal fibrosis 57 rCBF 57 disc degeneration 57 overactivity 57 sensory disturbances 57 neuro degeneration 57 attentional 57 autistic traits 57 sporadic ALS 57 neuron degeneration 57 neuronal degeneration 57 pathophysiological mechanisms 57 dopamine antagonists 57 neurotoxic effects 57 cognitive affective 57 ACh 57 cognitive dysfunctions 57 anticholinergic effects 57 Alzheimer pathology 57 oculomotor 57 dysgraphia 57 phenotypes 57 airway remodeling 57 comorbid anxiety 57 airway responsiveness 56 psychosocial variables 56 airway hyperresponsiveness 56 levodopa induced 56 developmental trajectories 56 neuroinflammation 56 Decety 56 brain neurochemistry 56 daytime sleepiness 56 Sjögren syndrome 56 remyelination 56 cortical thinning 56 neurocognitive functioning 56 inhibitory neurotransmitters 56 psychiatric comorbidity 56 extracellular dopamine 56 pathophysiologic 56 bronchopulmonary dysplasia 56 generalized epilepsy 56 adrenal function 56 neurosensory 56 dopamine signaling 56 visuospatial 56 affective disorders 56 chronicity 56 FMRP protein 56 NF1 56 hypopituitarism 56 neuropsychiatric disorder 56 hyperinsulinemia 56 GH deficiency 56 petit mal seizures 56 antidepressant efficacy 56 protein tau 56 Genetic predisposition 56 insulin resistance 56 endothelial dysfunction 56 neurologic sequelae 56 glutamate signaling 56 akinesia 56 impulsivity 56 EBV infection 56 epigenetic changes 56 comorbid depression 56 adult neurogenesis 56 progressive neurodegenerative disorder 56 atherosclerotic lesions 56 hyperalgesia 56 demyelination 56 emotional lability 56 amyloid pathology 56 depressive disorders 56 galanin 56 OSAHS 56 psychomotor retardation 56 artery stenosis 56 airway reactivity 56 glucocorticoid 56 mental retardation epilepsy 56 hypotonia 56 dysarthria 56 atherosclerotic disease 56 prolactin levels 56 Excessive daytime sleepiness 56 prenatal exposures 56 prodrome 56 Alzheimer disease pathology 56 neurologic dysfunction 56 Longitudinal studies 56 androgen depletion 56 synaptogenesis 56 neurodegenerative disorder 56 FTLD 56 hippocampal volumes 55 autonomic dysfunction 55 epilepsies 55 prostate carcinogenesis 55 delusions hallucinations 55 hypoperfusion 55 neural substrates 55 neuroinflammatory 55 hypothalamic pituitary adrenal axis 55 cortical activation 55 myoclonus 55 affective psychoses 55 cortisol secretion 55 depressive symptomatology 55 neuronal activity 55 fusiform 55 atherogenesis 55 white matter hyperintensities 55 neurotoxicity 55 monoamine 55 mild cognitive impairment 55 da mage 55 neuropathology 55 synaptic transmission 55 neuroprotective effects 55 metabolic dysfunction 55 carotid IMT 55 excitotoxicity 55 hepatic fibrosis 55 olfactory dysfunction 55 hyperammonemia 55 D2 receptor 55 mPFC 55 neuronal 55 Peutz Jeghers syndrome 55 glucose tolerance 55 narcolepsy cataplexy 55 activated microglia 55 anterior cingulate 55 genetic polymorphisms 55 dopaminergic 55 extrapyramidal 55 brain atrophy 55 auditory neuropathy 55 akinetic mutism 55 extrapyramidal symptoms EPS 55 atypical neuroleptics 55 tonic clonic seizures 55 pathophysiological 55 neurological diseases 55 metabolic acidosis 55 posterior cingulate 55 depression irritability 55 cardiac toxicity 55 cataract formation 55 posttraumatic 55 schizophrenia 55 CaMKII 55 pharmacological therapies 55 Obstructive sleep apnea 55 dysbindin gene 55 ASDs 55 epigenetic alterations 55 HbF 55 platelet activation 55 LRRK2 mutations 55 hereditary predisposition 55 nasal obstruction 55 neural degeneration 55 nongenetic 55 Hyperactivity 55 inherited neurological disorder 55 p# activation 55 laterality 55 muscarinic receptors 55 neuronal function 55 prefrontal regions 55 serotonin signaling 54 hippocampal 54 autistic tendencies 54 experimentally induced 54 ERK signaling 54 serotonin receptor 54 myotonic dystrophy 54 hypercalciuria 54 ovarian hormones 54 cortical regions 54 malformations 54 Alzheimers disease 54 cerebral vasospasm 54 dopamine receptors 54 penile erection 54 hyperprolactinemia 54 RLS symptoms 54 growth hormone secretion 54 locomotor 54 debilitating neurodegenerative disorder 54 T2DM 54 akathisia 54 beta1 integrin 54 neuroleptics 54 symptomatology 54 developmental disorders 54 obsessive compulsive behaviors 54 ataxia 54 frontal lobe dysfunction 54 neuroendocrine 54 magnetic stimulation 54 affective psychosis 54 microvascular disease 54 neurofibrillary tangles 54 syndrome FAS 54 neurologic deficits 54 MECP2 gene 54 dopamine D2 receptors 54 neurologic disorder 54 myelination 54 neurologic abnormalities 54 basal ganglia 54 acetabular dysplasia 54 neural correlates 54 CEACAM1 54 circadian rhythm sleep 54 biochemical imbalances 54 Alzheimer Disease AD 54 Chronic insomnia 54 neurologic diseases 54 amyloid β 54 recurrent miscarriages 54 hepatotoxicity 54 hypersomnia 54 endophenotypes 54 bone resorption 54 prenatal exposure 54 circadian misalignment 54 macrovascular disease 54 epileptogenic 54 repetitive behaviors 54 subsyndromal 54 APOE genotype 54 heterozygous familial 54 neurological disorder characterized 54 symptomology 54 epilepsy 54 enlarged amygdala 54 untreated celiac disease 54 Mood disorders 54 hemiplegia 54 enterocolitis 54 bradykinesia 54 alkalosis 54 urate levels 54 paroxysmal AF 54 infarcts 54 hepatocellular 54 locomotor activity 54 juvenile idiopathic arthritis 54 anticonvulsants 54 inhibitory 54 disk herniation 54 SNHL 54 airway inflammation 54 endothelial function 54 amyloid beta plaque 54 shorter telomere length 54 cerebral cortical 54 progranulin mutations 54 reflux symptoms 54 abstinent alcoholics 54 asthma exacerbations 54 mood dysregulation 54 Diabetic neuropathy 54 Cognitive dysfunction 54 acetylcholine receptor 54 aMCI precursor 54 mutant huntingtin protein 54 habitual snoring 54 polycystic ovary syndrome PCOS 54 Pharmacological 54 metabolic abnormality 54 cardiac hypertrophy 54 Nutritional deficiencies 54 adrenal insufficiency 54 familial clustering 54 myocardial ischemia 54 arterial calcification 54 neural mechanisms 54 analgesic effects 54 postoperative AF 54 neurogenesis 54 HGPS 54 NAFLD 54 nerve palsy 54 physiological reactions 54 ventricular remodeling 54 tic disorder 54 cerebellar vermis 54 Oppositional Defiant Disorder 54 neurological disorders 54 neural plasticity 54 ataxias 54 serotonergic 54 Pervasive Developmental Disorder 54 pathophysiological processes 54 anhedonia 54 daytime alertness 54 schizotypal traits 54 baroreceptor 54 typical antipsychotics 54 electroencephalographic 54 paralysis blindness 54 syndrome OSAS 54 Asperger Disorder 54 APOE ε4 54 superior temporal gyrus 54 striatal 54 neurological symptoms 54 vascular dysfunction 54 maturational 54 glutamatergic 54 structural abnormalities 54 Aβ 54 Essential tremor 54 degenerative disorders 54 metabolic disturbances 54 Suicidal ideation 54 torsade de pointes 54 gastrointestinal dysfunction 54 perceptual reasoning 53 serotonin transporter 53 attention-deficit/hyperactivity disorder 53 neurodegenerative diseases 53 psychomotor skills 53 frontotemporal 53 muscle degeneration 53 neurocognitive impairments 53 gamma oscillations 53 gastrointestinal symptoms 53 sensory gating 53 levodopa therapy 53 microvascular dysfunction 53 dementing 53 intermittent hypoxia 53 neurotransmitters serotonin 53 neovascular 53 hyperactivity 53 citalopram 53 nicotinic receptor 53 mitochondrial toxicity 53 onset seizures 53 TMEM#B 53 pharmacologic treatments 53 amyloid deposits 53 cardiac autonomic 53 arrhythmogenic 53 temporal cortex 53 neurological disorder affecting 53 pathogenic mechanisms 53 phenotype 53 PRODH deficiency 53 induce orthostatic hypotension 53 TEAEs 53 potentiation 53 fatty acid oxidation 53 5 HT1A 53 postnatally 53 premotor 53 synapse formation 53 neurotrophic 53 amnestic MCI 53 fibrotic disease 53 underlying molecular mechanisms 53 microalbuminuria 53 PTSD symptoms 53 amygdala neurons 53 clomipramine 53 progressive degeneration 53 neurogenic 53 muscle spasticity 53 pseudotumor cerebri 53 neuro developmental 53 MAO B 53 coagulopathy 53 microvascular complications 53 stereotypy 53 serotonin receptors 53 primidone 53 tic severity 53 GABA aminotransferase 53 cerebral infarction 53 AUDs 53 neurophysiological 53 synaptic proteins 53 Aß 53 motor neuropathy 53 excitotoxic 53 medial temporal 53 gastrointestinal motility 53 hippocampal neurogenesis 53 vitamin B1 deficiency 53 vasospasm 53 DQB1 * 53 non affective psychosis 53 beta endorphin 53 chronic pancreatitis 53 symptoms 53 neurosteroid 53 dyscalculia 53 SLC#A# [002] 53 cardiac dysfunction 53 noradrenergic 53 leptin deficient 53 neural circuits 53 cortical blindness 53 blepharospasm 53 generalized tonic clonic seizures 53 dissociative disorders 53 cardioprotection 53 inferior parietal 53 vascular cognitive impairment 53 hepatic steatosis 53 vestibular dysfunction 53 uncontrolled seizures 53 Mild cognitive impairment 53 congenital anomalies 53 unmeasured factors 53 bladder dysfunction 53 neural circuitry 53 anterior cingulate gyrus 53 Repeated concussions 53 reflux disease 53 IUGR 53 dysthymic disorder 53 #q# deletion syndrome 53 subcortical structures 53 causal pathways 53 disorders FASD 53 sensorineural hearing loss 53 psychotherapies 53 amblyopic 53 visual hallucinations 53 endotoxemia 53 β amyloid 53 excessive sleepiness 53 PNES 53 left ventricular dysfunction 53 chromosomal rearrangement 53 cognitive behavioral 53 glucose intolerance 53 brain plasticity 53 agnosia 53 demyelinating 53 rheumatic disease 53 hypoxemia 53 untreated sleep apnea 53 anticholinergic medications 53 NMDA receptor 53 knee OA 53 Parkinsons disease 53 neuropathologic 53 amyloid plaque formation 53 PON1 53 dopamine receptor 53 immunodeficiencies 53 disorder ASD 53 hyperphenylalaninemia HPA due 53 dopamine transporter 53 visuospatial processing 53 Depressive symptoms 53 Neuropsychological 53 hyperactivity impulsivity 53 hyperglycaemia 53 neurobiological mechanisms 53 e4 allele 53 coronary calcification 53 anticholinergic drugs 53 inherited mutations 53 Attention Deficit Hyperactive Disorder 53 gyrus 53 tardive dyskinesia 53 GABRA2 53 fluoxetine Prozac 53 glucocorticoids 53 Migraine headaches 53 hypoglycemic episodes 53 Lennox Gastaut Syndrome 53 imipramine 53 Sleep disordered breathing 53 parasomnias 53 pathophysiologic mechanisms 53 confusion disorientation 53 degenerative neurological diseases 53 macrovascular complications 53 nondepressed 53 nondemented 53 bullous 53 morbidities 53 opioid induced 53 mild TBI 53 autoregulation 53 overactivation 53 Hashimoto thyroiditis 53 endocannabinoid signaling 53 CatB 53 fibrosis 53 inflammatory markers 53 psychiatric comorbidities 53 dysphasia 53 vasodilatation 53 neurobiological disorder 53 arousals 53 HRQL 53 p# mutations 53 hydrops 53 childhood disintegrative disorder 53 hepatic encephalopathy HE 53 neurofibrillary 53 seizure disorders 52 vitamin B# deficiency 52 CLA supplementation 52 arrhythmias 52 repetitive transcranial magnetic stimulation 52 donepezil 52 neurocognition 52 retinal dysfunction 52 premenstrual syndrome PMS 52 airway constriction 52 vocal tics 52 pressor response 52 Prostatitis 52 colorectal carcinogenesis 52 myotonia 52 spastic cerebral palsy 52 thrombophilia 52 vesicoureteral reflux 52 interstitial fibrosis 52 neuro developmental disorder 52 tardive dyskinesia TD 52 dopaminergic neurons 52 progressive neurodegenerative disease 52 LUTS 52 cortices 52 Tardive dyskinesia 52 endogenous cannabinoid 52 predisposing factors 52 multi infarct dementia 52 neurodegenerative disease 52 developmental delays 52 multisystemic 52 cholinergic 52 Major Depressive Disorder 52 CNTNAP2 52 Dr. Gozal 52 familial adenomatous polyposis 52 retinitis pigmentosa RP 52 tonic clonic 52 Alzheimer disease AD 52 dorsolateral prefrontal cortex 52 microbleeds 52 POMC neurons 52 ADHD 52 muscular dystrophies 52 NADPH oxidase 52 pharmacological approaches 52 HRQOL 52 Singh Manoux 52 glucocorticoid receptors 52 dissociative symptoms 52 urinary excretion 52 serum calcium 52 longitudinal studies 52 atherosclerosis 52 lymphocyte activation 52 neuropathic 52 elevated homocysteine 52 OAB symptoms 52 Polyneuropathy 52 GABA gamma aminobutyric acid 52 muscle rigidity 52 Alzheimer disease cognitive impairment 52 Anxiety disorders 52 familial ALS 52 temporal lobes 52 suicidal behaviors 52 hypercalcaemia 52 nystagmus 52 euthymic 52 persistent pulmonary hypertension 52 neuroimaging 52 involuntary tics 52 primary generalized tonic 52 gastrointestinal disturbances 52 Parkinsonian symptoms 52 neuroleptic 52 hypogonadotropic hypogonadism 52 neurotransmitter GABA 52 primary biliary cirrhosis 52 variceal bleeding 52 mu opioid 52 nicotinic receptors 52 maintaining cardiorespiratory fitness 52 IgA deficiency 52 progranulin 52 deafness blindness 52 preterm deliveries 52 attention-deficit/hyperactivity disorder ADHD 52 perirhinal cortex 52 physiological mechanisms 52 subclinical inflammation 52 clefting 52 cholinesterase inhibitors 52 convulsive seizures 52 MS relapses 52 CYP #A# 52 hypometabolism 52 bowel dysfunction 52 Observational studies 52 dopamine antagonism 52 desipramine 52 neuronal circuits 52 hyperresponsiveness 52 ADPKD 52 cognitively normal 52 autoimmune thyroiditis 52 nNOS 52 postural instability 52 Posttraumatic stress disorder 52 neural pathways 52 venlafaxine Effexor 52 calcium excretion 52 brain malformation 52 apneas 52 neurobehavioral disorder 52 APOE e4 52 neuropathies 52 CLBP 52 pediatric bipolar disorder 52 irreversible neurological 52 dyskeratosis congenita 52 pathological hallmarks 52 interindividual variability 52 hyperactivation 52 6 OHDA 52 severe hypoglycemia 52 COMT 52 gait disturbance 52 etiologic 52 myopathies 52 neuro behavioral 52 CNTNAP2 gene 52 idiopathic generalized epilepsy 52 Epileptic seizures 52 visuospatial abilities 52 glucose metabolism 52 tremor rigidity 52 juvenile idiopathic arthritis JIA 52 adenotonsillectomy 52 cerebral atrophy 52 dietary DHA 52 #q#.# deletion syndrome 52 oxcarbazepine 52 Cushing syndrome 52 uncontrolled epilepsy 52 psychopathological disorders 52 Cholinesterase inhibitors 52 gastric carcinogenesis 52 recurrent infections 52 basal cell nevus syndrome 52 term potentiation 52 acamprosate 52 Parkinsonism 52 psychiatric morbidity 52 posttraumatic stress disorder 52 L DOPA 52 IGFD 52 physiological arousal 52 thyrotropin 52 mice genetically altered 52 P#X# receptors 52 Li Huei Tsai 52 de novo mutations 52 thyroid hormone levels 52 REM sleep behavior 52 Myotonic dystrophy 52 steatohepatitis 52 thrombotic complications 52 nonpharmacologic 52 Generalized anxiety disorder 52 Prefrontal 52 Lennox Gastaut syndrome 52 coprolalia 52 glucocorticoid therapy 52 physiologic mechanisms 52 neuro degenerative disease 52 chromium picolinate supplementation 52 anatomical abnormalities 52 comorbid conditions 52 liver fibrosis 52 GABAergic interneurons 52 allodynia 52 myoclonic 52 uric acid levels 52 thyrotropin levels 52 retinal degeneration 52 Cognitive behavioral 52 primary ovarian insufficiency 52 dysmenorrhoea 52 diabetic gastroparesis 52 hyperreflexia 52 denervation 52 endogenous opioids 52 polyarticular 52 thyroiditis 52 unprovoked seizures 52 unmeasured confounders 52 nAChR 52 striatal dopamine 52 mitochondrial mutations 52 hereditary deafness 52 Borderline personality 52 idiopathic 52 Cockayne syndrome 52 dysgenesis 52 chromosomal anomaly 52 neurotransmission 52 polyuria 52 involuntary movements 52 knee osteoarthritis OA 52 autoimmune thyroid 52 cortical plasticity 52 safinamide 52 Bardet Biedl Syndrome 52 dominantly inherited 52 hyperintense lesions 52 choroidal neovascularization 52 postoperative delirium 52 confounding variables 52 ventricular tachyarrhythmia 52 pyramidal neurons 52 prosopagnosia 52 systemic inflammation 52 anxiety disorders 52 vascular reactivity 52 antitumor efficacy 52 GABAB receptors 52 amblyopia 52 KIBRA 52 airflow obstruction 52 auditory pathways 52 antidepressants SSRIs 52 bulimia nervosa 52 intracranial hypertension 52 metabolic parameters 52 leptin deficiency 52 missense mutations 52 Gleevec inhibits 52 FXTAS 52 pharmacological treatments 52 parahippocampal gyrus 52 ventromedial 52 receptor subtypes 52 psychiatric illnesses 52 behavioral disorders 52 anterior temporal 52 Severe Primary IGFD 51 baroreflex 51 ABCA1 51 Topiramate 51 neurological dysfunctions 51 axonal transport 51 Ascherio 51 occipital regions 51 obstructive sleep 51 potent inhibitors 51 neurocircuitry 51 endogenous opioid 51 involuntary muscle contractions 51 aetiological 51 bone deformities 51 anosognosia 51 chromosomal aberrations 51 impulsive behavior 51 lung fibrosis 51 gliosis 51 GPi 51 poststroke depression 51 causative gene 51 AChE inhibitors 51 intestinal microflora 51 chorea 51 decrements 51 microglial cells 51 middle frontal gyrus 51 Genetic variants 51 ectodermal dysplasia 51 astrocytic 51 cerebellar hypoplasia 51 JAK STAT signaling 51 dyskinesia 51 pharmacologic 51 predisposing factor 51 psychobiological 51 Parkinson disease neurodegenerative disorder 51 TGF beta signaling 51 dermatomyositis 51 genotoxic stress 51 mild retardation 51 folate deficiency 51 molecular mechanism 51 cardioprotective effects 51 diastolic function 51 upper airway obstruction 51 neurodegenerative disorders 51 psychopathology 51 PAOD 51 cognitively intact 51 mGluR5 antagonist 51 dopamine D2 receptor 51 LRRK2 mutation 51 C1q 51 hyperacute 51 Generalized Anxiety Disorder 51 monogenic 51 muscle atrophy 51 hypochondriasis 51 dysfunctional voiding 51 dysmotility 51 Mental retardation 51 pituitary hormone 51 glutamate neurotransmission 51 neuritic 51 serotonin neurons 51 Symadex 51 L dopa 51 sortilin 51 gyri 51 repolarization 51 cardiac conduction 51 temporal lobe epilepsy 51 recurrent miscarriage 51 muscular atrophy 51 receptor subtype 51 amnestic 51 plasma pharmacokinetics 51 insulin secretion 51 intractable epilepsy 51 hippocampal dysfunction 51 microglial 51 motor neuron diseases 51 recurrent seizures 51 cAMP signaling 51 brain shrinkage 51 NMDA receptor antagonists 51 comorbid psychiatric disorders 51 IL 1ß